University of Utah
Salt Lake City, Utah, 84108, United States
NCT Number: NCT05497154
The purpose of this study is to develop and operationalize key procedures for physical therapists (n = 12) to address patients who are at risk for or have opioid misuse (OM). The investigators will train physical therapists in procedures to: 1) engage patients at risk for OM in conversations about appropriate opioid use, 2) screen and 3) assess these patients for OM and, 4) refer patients for further treatment if OM is suspected. The investigators will employ a modified Delphi approach to iteratively refine and operationalize the procedures and to arrive at a finalized procedure manual followed by an evaluation of the implementation of these procedures.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Salt Lake City, Utah, 84108, United States
The purpose of this study is to develop and operationalize key procedures for physical therapists (n = 12) to address patients who are at risk for or have OM. The investigators will train physical therapists in procedures to: 1) engage patients at risk for OM in conversations about appropriate opioid use, 2) screen and 3) assess these patients for OM and, 4) refer patients for further treatment if OM is suspected. The investigators will employ a modified Delphi approach to iteratively refine and operationalize the procedures and to arrive at a finalized procedure manual followed by an evaluation of the implementation of these procedures. Approximately 4 months following the development of the manual and the distribution of the finalized manual, the investigators will conduct semi-structured interviews to determine the barriers and facilitators to implementing the procedures learned in the training.
Our aims are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The training will be composed of 4 separate training sessions provided every 2 - 4 weeks. During the 1st session (45 minutes), the investigators will educate the physical therapist about the different categories of opioid use including opioid misuse (OM) and the risks associated with OM as well as training to engage the patient in a conversation about opioid use. The 2nd and 3rd sessions (30 minutes each) involve training in procedures to screen and assess patients at risk for OM, respectively. The 4th session (30 minutes) involves training in procedures to refer patients to a specialist or a primary care provider for further treatment if OM is suspected.
Time frame: Baseline, immediate post training, 4 months after last training session
The DDPPQ is a 20 item tool used to measure the attitudes of health care providers related to the management of patients misusing drugs and contains 5 subscales (Role Adequacy: 7 items; Role Legitimacy: 2 items; Role Support: 3 items; Role Self-esteem: 4 items; Job Satisfaction: 4 items) Each item is scored on a 7-point scale (1 = strongly agree to 7 = strongly disagree). Each item was modified to asses the health care providers' attitudes about managing patients with opioid misuse.
Time frame: 4 months after the last training session
Semi-structured interviews to assess barriers and facilitators of implementing the procedures learned in the training
Time frame: Immediate post training
Proportion of physical therapists who agreed to attend the training that attended all training sessions
Time frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report engaging patients in conversations about opioid misuse,
Time frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report screening for opioid misuse
Time frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report assessing patients for opioid misuse
Time frame: Approximately 4 months after last training session
Percentage of physical therapists who attended the training that report referring for opioid misuse
Time frame: Immediately after each of the 4 training sessions.
The investigators will conduct focus groups after each training session. All sessions will be analyzed together to qualitatively assess the physical therapists' receptivity to the procedures learned in the training sessions.
Time frame: Baseline, immediately post training and to approximately 4 months after the last training session
Questions were adapted: "How often do you ask patients about alcohol problems?" was modified to: "How often do you ask patients about problems with prescription opioid medication misuse? 4 additional questions were similarly modified ([1] How often do you formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [2] How often do you assess patients' readiness to change their prescription opioid medication misuse behaviors?; [3] How often do you discuss/advise patients to change their prescription opioid medication misuse behaviors?; [4] How often do you refer patients with prescription opioid medication misuse for further assessments or interventions?). Scoring: Never, Rarely (less than 10% of the time), Occasionally (about 30% of the time), Sometimes (about 50% of the time), Frequently (about 70% of the time), Usually (about 90% of the time), Every time.
Time frame: Approximately 4 months after the last training session.
At the end of the study after the individual interviews, the investigators will finalize the manual of opioid misuse procedures for physical therapists.
Time frame: Baseline, immediately post training and to approximately 4 months after the last training session
These questions were adapted from a survey developed to improve health care providers' management of patients with alcohol problems. The questions are: ([1] I am confident in my ability to ask patients about prescription opioid medication misuse, [2] I am confident in my ability to formally screen patients for prescription opioid medication misuse using screening instruments, such as the Current Opioid Misuse Measure or other tools; [3] I am confident in my ability to assess patients' readiness to change their prescription opioid medication misuse behaviors; [4] I am confident in my ability to discuss/advise patients to change their prescription opioid medication misuse behaviors; [5] I am confident in my ability to refer patients with prescription opioid medication misuse for further assessments or interventions?). Each confidence with management practice question was scored on a 7-point Likert scale (1 = no confidence; 7 = high confidence).
University of Utah
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04941950
Chemically-Induced Disorders, Mental Disorders
Bridgeport, Connecticut, United States
View Trial DetailsNCT05182606
Chemically-Induced Disorders, Chronic Pain
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05503186
Chemically-Induced Disorders, Mental Disorders
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06554431
Chemically-Induced Disorders, Chronic Pain
The Bronx, New York, United States
View Trial Details